Seeing Is Believing
ESPR is currently covered by 6 analysts with an average price target of $24.07. This is a potential upside of $21.6 (874.49%) from yesterday's end of day stock price of $2.47.
Esperion Therapeutics's activity chart (see below) currently has 172 price targets and 157 ratings on display. The stock rating distribution of ESPR is 5.56% SELL, 77.78% BUY and 16.67% HOLD.
Analysts average stock forecasts to be materialized ratio is 42.12% with an average time for these price targets to be met of 124.67 days.
Highest price target for ESPR is $16, Lowest price target is $2.5, average price target is $24.07.
Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 08-Nov-2024. First documented stock forecast 27-Oct-2014.
Currently out of the existing stock ratings of ESPR, 2 are a SELL (5.56%), 28 are a BUY (77.78%), 6 are a HOLD (16.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$16
$13.88 (654.72%)
$16
13 days ago
(08-Nov-2024)
0/10 (0%)
$13.72 (601.75%)
Buy
$6
$3.88 (183.02%)
$8
3 months 8 days ago
(13-Aug-2024)
0/9 (0%)
$4.2 (233.33%)
Hold
$2.5
$0.38 (17.92%)
5 months 1 days ago
(20-Jun-2024)
2/4 (50%)
$0.21 (9.17%)
14
Hold
$9
1 years 1 days ago
(20-Nov-2023)
4/8 (50%)
$2.84 (46.10%)
92
Hold
$3
$0.88 (41.51%)
1 years 8 months 1 days ago
(20-Mar-2023)
4/7 (57.14%)
$1.46 (94.81%)
80
What is ESPR (Esperion Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on ESPR (Esperion Therapeutics) with a proven track record?
Which analyst has the most public recommendations on ESPR (Esperion Therapeutics)?
Which analyst is the currently most bullish on ESPR (Esperion Therapeutics)?
Which analyst is the currently most reserved on ESPR (Esperion Therapeutics)?